Drug Manufacturing and Formulation Contract II
SAM.GOV Due: May 9, 2025 at 09:00 PM UTC
In-Active Sources Sought SBP Source Url

Summary

The Drug Manufacturing and Formulation Contract II opportunity is a sources sought notice issued by the National Institutes of Health (NIH) aimed at identifying potential contractors capable of fulfilling the requirements for the manufacturing, documentation, formulation, fill and finish, packaging, and labeling of investigational drug products. This contract emphasizes the need for compliance with current good manufacturing practices (cGMP) and adherence to regulations set forth by the FDA, WHO, and other relevant organizations. Contractors interested in this opportunity should possess the necessary technical capabilities, resources, and organizational compliance to successfully execute the contract activities, and should ideally be classified as a 'Qualified Vendor' by the Office of Research Services (ORS). This opportunity is particularly suited for small businesses due to its partial small business set-aside designation.
Description

Please take a moment to thoroughly review the attached Statement of Work (SOW), which outlines the full scope and details of the drug formulation and manufacturing contract requirement.

The goal of the contract is to complete all the manufacturing, documentation, formulation, fill and fin

Entities
HAHSDO
Department of Health and Human Services
NIOH
National Institutes of Health
NAICS
325
Set Aside
SBP : Partial Small Business Set-Aside (FAR 19.5)
Place of Performance
Rockville , Maryland 20852
Point of Contact
Full Name Email Phone Type
Dr. William H. M. Etti [email protected] 3014024422 primary
Attachments
  • New+DFMC+SOW_DRAFT+01Feb25+clean.docx